BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29135937)

  • 1. Relax, Cool Down and Scaffold: How to Restore Surface Expression of Folding-Deficient Mutant GPCRs and SLC6 Transporters.
    Asjad HMM; Nasrollahi-Shirazi S; Sucic S; Freissmuth M; Nanoff C
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When transporters fail to be transported: how to rescue folding-deficient SLC6 transporters.
    Sucic S; Kasture A; Mazhar Asjad HM; Kern C; El-Kasaby A; Freissmuth M
    J Neurol Neuromedicine; 2016 Dec; 1(9):34-40. PubMed ID: 28405636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers.
    Bhat S; Newman AH; Freissmuth M
    Biochem Soc Trans; 2019 Jun; 47(3):861-874. PubMed ID: 31064865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transporters.
    Chiba P; Freissmuth M; Stockner T
    Pharmacol Res; 2014 May; 83(100):63-73. PubMed ID: 24316454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC6 Transporter Folding Diseases and Pharmacochaperoning.
    Freissmuth M; Stockner T; Sucic S
    Handb Exp Pharmacol; 2018; 245():249-270. PubMed ID: 29086036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.
    El-Kasaby A; Koban F; Sitte HH; Freissmuth M; Sucic S
    J Biol Chem; 2014 Oct; 289(42):28987-9000. PubMed ID: 25202009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone.
    El-Kasaby A; Boytsov D; Kasture A; Krumpl G; Hummel T; Freissmuth M; Sandtner W
    Mol Pharmacol; 2024 Jun; 106(1):56-70. PubMed ID: 38769018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Rescue of a Misfolded
    Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal Unfolding of the Human Serotonin Transporter: Differential Effect by Stabilizing and Destabilizing Mutations and Cholesterol on Thermodynamic and Kinetic Stability.
    Ponleitner M; Szöllősi D; El-Kasaby A; Koban F; Freissmuth M; Stockner T
    Mol Pharmacol; 2022 Feb; 101(2):95-105. PubMed ID: 34866045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter.
    Koban F; El-Kasaby A; Häusler C; Stockner T; Simbrunner BM; Sitte HH; Freissmuth M; Sucic S
    J Biol Chem; 2015 May; 290(21):13263-78. PubMed ID: 25869136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates.
    Bhat S; Hasenhuetl PS; Kasture A; El-Kasaby A; Baumann MH; Blough BE; Sucic S; Sandtner W; Freissmuth M
    J Biol Chem; 2017 Oct; 292(40):16773-16786. PubMed ID: 28842491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
    El-Kasaby A; Kasture A; Koban F; Hotka M; Asjad HMM; Kubista H; Freissmuth M; Sucic S
    Neuropharmacology; 2019 Dec; 161():107572. PubMed ID: 30885608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.
    El-Kasaby A; Just H; Malle E; Stolt-Bergner PC; Sitte HH; Freissmuth M; Kudlacek O
    J Biol Chem; 2010 Dec; 285(50):39201-10. PubMed ID: 20889976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
    Bhat S; El-Kasaby A; Freissmuth M; Sucic S
    Pharmacol Ther; 2021 Jun; 222():107785. PubMed ID: 33310157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters.
    Bhat S; Guthrie DA; Kasture A; El-Kasaby A; Cao J; Bonifazi A; Ku T; Giancola JB; Hummel T; Freissmuth M; Newman AH
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):503-516. PubMed ID: 33860180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific ligands as pharmacological chaperones: The transport of misfolded G-protein coupled receptors to the cell surface.
    Nakamura M; Yasuda D; Hirota N; Shimizu T
    IUBMB Life; 2010 Jun; 62(6):453-9. PubMed ID: 20503438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.
    Farr CV; El-Kasaby A; Freissmuth M; Sucic S
    Front Synaptic Neurosci; 2020; 12():588954. PubMed ID: 33192443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperones and G protein-coupled receptor maturation and pharmacology.
    Tao YX
    Mol Cell Endocrinol; 2020 Jul; 511():110862. PubMed ID: 32389798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.
    Ulloa-Aguirre A; Zariñán T; Jardón-Valadez E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.